Get the Stockscreener App
0.42
10.01%
0.0382
Promis Neurosciences Inc stock is traded at $0.42, with a volume of 1.10M.
It is up +10.01% in the last 24 hours and down -4.61% over the past month.
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
See More
Previous Close:
$0.3818
Open:
$0.39
24h Volume:
1.10M
Relative Volume:
0.79
Market Cap:
$22.60M
Revenue:
-
Net Income/Loss:
$-563.30K
P/E Ratio:
-2.1042
EPS:
-0.1996
Net Cash Flow:
$-22.23M
1W Performance:
+7.80%
1M Performance:
-4.61%
6M Performance:
-15.37%
1Y Performance:
-56.02%
1-Day Range:
$0.39
$0.45
1-Week Range:
$0.35
$0.45
52-Week Range:
$0.35
$1.59
Promis Neurosciences Inc Stock (PMN) Company Profile
Name
Promis Neurosciences Inc
Sector
Industry
Phone
416-847-6898
Address
SUITE 200, 1920 YONGE STREET, TORONTO
Compare PMN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PMN
Promis Neurosciences Inc
|
0.42 | 20.55M | 0 | -563.30K | -22.23M | -0.1996 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Promis Neurosciences Inc Stock (PMN) Latest News
Promis Neurosciences (NASDAQ:PMN) Earns Buy Rating from HC Wainwright - Defense World
HC Wainwright & Co. Reiterates ProMIS Neurosciences (PMN) Buy Recommendation - Nasdaq
PMN: HC Wainwright & Co. Reiterates Buy Rating with Unchanged Pr - GuruFocus
What sentiment indicators say about ProMIS Neurosciences Inc. stock - newser.com
Will ProMIS Neurosciences Inc. stock gain from strong economyJuly 2025 Price Swings & High Return Trade Guides - newser.com
Will ProMIS Neurosciences Inc. (23J0) stock hit Wall Street targetsMarket Trend Summary & Verified Swing Trading Watchlists - newser.com
Will ProMIS Neurosciences Inc. (23J0) stock beat value stocksMarket Performance Recap & Smart Swing Trading Alerts - newser.com
Will ProMIS Neurosciences Inc. stock outperform Nasdaq indexEarnings Beat & Free Weekly Watchlist of Top Performers - newser.com
Why analysts raise outlook for ProMIS Neurosciences Inc. (23J0) stockJuly 2025 Sentiment & Free Reliable Trade Execution Plans - newser.com
How ProMIS Neurosciences Inc. stock responds to policy changesRate Cut & Weekly Chart Analysis and Trade Guides - newser.com
Will ProMIS Neurosciences Inc. stock split again soonWeekly Investment Summary & Real-Time Market Sentiment Reports - newser.com
Can ProMIS Neurosciences Inc. stock sustain institutional interest2025 Bull vs Bear & Precise Swing Trade Entry Alerts - newser.com
ProMIS Neurosciences Approves Key Shareholder Proposals - MSN
How strong is ProMIS Neurosciences Inc. (23J0) stock earnings growthQuarterly Investment Review & AI Enhanced Execution Alerts - newser.com
Will ProMIS Neurosciences Inc. (23J0) stock sustain bullish trend into 2025Portfolio Risk Summary & Risk Adjusted Swing Trade Ideas - newser.com
ProMIS Neurosciences shareholders approve share consolidation proposal By Investing.com - Investing.com Australia
ProMIS Neurosciences shareholders approve share consolidation proposal - Investing.com
Can ProMIS Neurosciences Inc. (23J0) stock sustain margin levelsQuarterly Portfolio Review & Fast Gain Stock Tips - newser.com
Why retail investors pile into ProMIS Neurosciences Inc. stockRecession Risk & Verified Chart Pattern Trade Signals - newser.com
Why ProMIS Neurosciences Inc. (23J0) stock is a strong analyst pick - newser.com
How ProMIS Neurosciences Inc. stock compares to industry benchmarksEarnings Summary Report & Daily Stock Momentum Reports - newser.com
ProMIS Neurosciences Inc. stock retracement – recovery analysis2025 Geopolitical Influence & Growth Focused Entry Reports - newser.com
Real time scanner hits for ProMIS Neurosciences Inc. explainedJuly 2025 Action & Target Return Focused Picks - newser.com
Guggenheim Maintains ProMIS Neurosciences (PMN) Buy Recommendation - Nasdaq
Promis Neurosciences Inc Stock (PMN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.38%
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):